1. Li, Xubin, Zhang, Mengqiao, Yu, Xue, Gao, Qiang, Kang, Chunbo. 2022. AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer. In Journal of oncology, 2022, 5054324. doi:10.1155/2022/5054324. https://pubmed.ncbi.nlm.nih.gov/35578598/
2. Jeong, Wooyoung, Kim, Jinyoung, Ahn, Suzie E, Han, Jae Yong, Song, Gwonhwa. 2012. AHCYL1 is mediated by estrogen-induced ERK1/2 MAPK cell signaling and microRNA regulation to effect functional aspects of the avian oviduct. In PloS one, 7, e49204. doi:10.1371/journal.pone.0049204. https://pubmed.ncbi.nlm.nih.gov/23145124/
3. Jeong, Wooyoung, Kim, Hee Seung, Kim, Yong Beom, Han, Jae Yong, Song, Gwonhwa. 2012. Paradoxical expression of AHCYL1 affecting ovarian carcinogenesis between chickens and women. In Experimental biology and medicine (Maywood, N.J.), 237, 758-67. doi:10.1258/ebm.2012.011433. https://pubmed.ncbi.nlm.nih.gov/22826361/
4. Wischhof, Lena, Adhikari, Aasha, Mondal, Mrityunjoy, Nicotera, Pierluigi, Bano, Daniele. 2022. Unbiased proteomic profiling reveals the IP3R modulator AHCYL1/IRBIT as a novel interactor of microtubule-associated protein tau. In The Journal of biological chemistry, 298, 101774. doi:10.1016/j.jbc.2022.101774. https://pubmed.ncbi.nlm.nih.gov/35218773/